Emcure Pharma files DRHP for proposed IPO, offer size in the range Rs 4,500-5000 crores
In FY21, the company reported a net profit of Rs 419 crores compared to Rs 101 crores in FY 20 and consolidated total income at Rs 6092 crores, up 19% Y-o-Y
In FY21, the company reported a net profit of Rs 419 crores compared to Rs 101 crores in FY 20 and consolidated total income at Rs 6092 crores, up 19% Y-o-Y
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
Subscribe To Our Newsletter & Stay Updated